Literature DB >> 18852597

Implantation of a permanent pacemaker in a pregnant woman under the guidance of electrophysiologic signals and transthoracic echocardiography.

Claudio Pedrinazzi1, Pietro Gazzaniga, Ornella Durin, Daniela Tovena, Giuseppe Inama.   

Abstract

We describe the case of a 30-year-old pregnant woman who underwent pacemaker implantation for recurrent syncope caused by sinus arrest. In order to minimize radiation exposure, which may potentially have teratogenic effects, we decided to perform pacemaker implantation by means of a hybrid technique involving the evaluation of electrophysiologic signals and transthoracic echocardiographic imaging to guide lead positioning within the right ventricle. After the procedure, the patient was always asymptomatic and had no recurrences of syncope. Six months later, she experienced uncomplicated natural labor, and the newborn was absolutely healthy. On a 10-month follow-up examination, the lead position was still optimal, and ventricular sensing and pacing thresholds were good. Our case demonstrates that pacemaker implantation under the guidance of electrophysiologic signals and transthoracic echocardiographic imaging, with only a short view by pulsed fluoroscopy in order to verify the correct lead position, is an effective and well-tolerated procedure in pregnant women.

Entities:  

Mesh:

Year:  2008        PMID: 18852597     DOI: 10.2459/JCM.0b013e3283100edc

Source DB:  PubMed          Journal:  J Cardiovasc Med (Hagerstown)        ISSN: 1558-2027            Impact factor:   2.160


  2 in total

1.  Classical fluoroscopy criteria poorly predict right ventricular lead septal positioning by comparison with echocardiography.

Authors:  Fabien Squara; Didier Scarlatti; Philippe Riccini; Gauthier Garret; Pamela Moceri; Emile Ferrari
Journal:  J Interv Card Electrophysiol       Date:  2018-03-13       Impact factor: 1.900

2.  Cardiac Interventions in Pregnant Patients without Fluoroscopy.

Authors:  Volkan Tuzcu; Enes Elvin Gul; Abdullah Erdem; Hacer Kamali; Turkay Saritas; Cem Karadeniz; Celal Akdeniz
Journal:  Pediatr Cardiol       Date:  2015-05-07       Impact factor: 1.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.